{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:01:49Z","timestamp":1792789309860,"version":"4.5.0"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T00:00:00Z","timestamp":1132617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p><jats:bold>Aims<\/jats:bold> :\u2002Comedo carcinoma is generally regarded as the subtype of ductal carcinoma <jats:italic>in situ<\/jats:italic> (DCIS) most likely to progress to invasive carcinoma. Increased angiogenesis could be associated with an enhanced risk of progression and might therefore be a marker of poor prognosis, as can be demonstrated for invasive breast tumours. Therefore, the present study investigates the correlations between the expression of oncoproteins (HER2, HER1\/EGFR), angiogenic growth factors (VEGF and PD\u2010ECGF\/TP) and microvessel density (MVD) in DCIS.<\/jats:p><jats:p><jats:bold>Methods and results<\/jats:bold> :\u2002Forty\u2010six breast cancer specimens of DCIS were tested immunohistochemically for the expression of angiogenic factors and oncoproteins. Different vascular distribution patterns of DCIS were examined semiquantitatively. Our results showed a significantly inverse correlation between HER1\/EGFR and comedo\u2010type DCIS (<jats:italic>P\u2003=<\/jats:italic>\u20030.048), but HER1\/EGFR expression seemed to be independent of HER2 overexpression. VEGF expression was significantly associated with endoglin expression (<jats:italic>P\u2003=<\/jats:italic>\u20030.031) and the cuffing phenomenon (<jats:italic>P\u2003=<\/jats:italic>\u20030.017).<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002The significantly inverse correlation between HER1\/EGFR and comedo\u2010type DCIS and the observation that VEGF and the other angiogenic factors tested are independent of HER2 overexpression, suggest that progression of comedo\u2010type DCIS and angiogenesis in breast carcinoma are not regulated via the HER1\/EGFR or HER2 pathway.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2005.02299.x","type":"journal-article","created":{"date-parts":[[2006,3,30]],"date-time":"2006-03-30T09:15:44Z","timestamp":1143710144000},"page":"617-624","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Angiogenic potential of ductal carcinoma <i>in situ<\/i> (DCIS) of human breast"],"prefix":"10.1111","volume":"47","author":[{"given":"G","family":"Vogl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hauser\u2010Kronberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,22]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90344-3"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910550305"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101033240101"},{"key":"e_1_2_7_5_2","first-page":"9","article-title":"Intratumour microvessel density as a prognostic factor in cancer","volume":"147","author":"Weidner N","year":"1995","journal-title":"Am. J. Pathol."},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014730829872"},{"key":"e_1_2_7_7_2","first-page":"6667","article-title":"Active signaling by HER\u20102\/neu in a subpopulation of HER\u20102\/neu\u2010overexpressing ductal carcinoma in situ: clinicopathological correlates","volume":"62","author":"DiGiovanna MP","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2001.01686.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941201)74:11<2972::AID-CNCR2820741113>3.0.CO;2-Z"},{"key":"e_1_2_7_10_2","first-page":"356","volume-title":"The breast","author":"Elston CW","year":"1998"},{"key":"e_1_2_7_11_2","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER\u2010ICA) in breast cancer tissue","volume":"8","author":"Remmele W","year":"1987","journal-title":"Pathologe"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.8.614"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<207::AID-PATH758>3.0.CO;2-4"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1995"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00248-4"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(05)80606-5"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.10.778"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.14.1059"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023958324448"},{"key":"e_1_2_7_20_2","first-page":"1398","article-title":"Epidermal\u2010growth\u2010factor receptor status as predictor of early recurrence of and death from breast cancer","volume":"1","author":"Sainsbury JR","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_7_21_2","first-page":"3823","article-title":"Quantitative estimation of epidermal growth factor receptor and c\u2010erbB\u20102 in human breast cancer","volume":"56","author":"Robertson KW","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01612.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0080183"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199708)182:4<414::AID-PATH897>3.0.CO;2-Q"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.49"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<285::AID-PATH238>3.0.CO;2-R"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2005.02299.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2005.02299.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:59:25Z","timestamp":1697176765000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2005.02299.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,22]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1365-2559.2005.02299.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02299.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,22]]},"assertion":[{"value":"2005-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}